Outshine the giants: these 17 early-stage AI stocks could fund your retirement.
To own IQVIA, you need to believe that its scale in data, CRO services, and AI can translate complex drug development and commercialization into durable earnings power. The upcoming second quarter release, with AI-driven tailwinds and stronger high-margin segments expected, supports that view but does not fully remove near term concerns around CRO pricing pressure and the risk that heavier AI use by clients could eventually erode IQVIA’s pricing power.
Against this backdrop, IQVIA’s March 2026 launch of the IQVIA.ai platform with NVIDIA looks especially relevant. It connects directly to the AI themes underpinning the second quarter expectations and could strengthen IQVIA’s competitive moat in research, real world data, and commercial analytics. For investors focused on catalysts, this platform may be just as important as the quarterly numbers in shaping how resilient IQVIA’s AI advantage really is over time.
Yet while AI may support growth, investors should also be aware of the rising mix of lower margin services and what that could mean for...
Read the full narrative on IQVIA Holdings (it's free!)
IQVIA Holdings' narrative projects $19.7 billion revenue and $2.0 billion earnings by 2029. This requires 5.8% yearly revenue growth and about a $0.6 billion earnings increase from $1.4 billion today.
Uncover how IQVIA Holdings' forecasts yield a $226.95 fair value, a 9% upside to its current price.
Some of the most optimistic analysts already saw AI as a game changer, assuming revenue could reach about US$20.9 billion and earnings US$2.5 billion by 2029, which is a far brighter path than the consensus view. In light of IQVIA’s AI boosted second quarter expectations and the risk of margin pressure from more RWE and FSP work, you should weigh whether this bullish scenario still fits or needs a rethink as new data comes in.
Explore 3 other fair value estimates on IQVIA Holdings - why the stock might be worth as much as 59% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Opportunities like this don't last. These are today's most promising picks. Check them out now:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com